Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Post

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
The Medical Journal of Australia|March 12, 2015
Evolving views and practices of antiretroviral treatment prescribers in AustraliaLimin Mao, Philippe C G Adam, Susan Kippax, et al.
Immunological Reviews|June 19, 2013
HIV and co-infectionsChristina C Chang, Megan Crane, Jingling Zhou, et al.
Journal of Hepatology|February 15, 2003
The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infectionAnthony J Freeman, Yong Pan, Charles E Harvey, et al.
The Journal of Infectious Diseases|August 21, 2004
Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug useAnthony J Freeman, Rosemary A Ffrench, Jeffrey J Post, et al.
Sexual Health|June 7, 2019
A national study of the clinical management of HIV-positive women in Australia: what are the successes and where are the gaps?Michelle L Giles, Aleece MacPhail, Charlotte Bell, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
The Medical Journal of Australia|May 27, 2025
Remote patient monitoring for managing acute COVID-19, and mortality and hospital use in Sydney, New South Wales, 2021-22: a retrospective observational cohort studyMyong Gyu Kim, Phuong Thao Phan, Cambell McMaster, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
The Journal of Infectious Diseases|May 4, 2004
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohortJeffrey J Post, Yong Pan, Anthony J Freeman, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
The Medical Journal of Australia|March 12, 2015
Evolving views and practices of antiretroviral treatment prescribers in AustraliaLimin Mao, Philippe C G Adam, Susan Kippax, et al.
Immunological Reviews|June 19, 2013
HIV and co-infectionsChristina C Chang, Megan Crane, Jingling Zhou, et al.
Journal of Hepatology|February 15, 2003
The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infectionAnthony J Freeman, Yong Pan, Charles E Harvey, et al.
The Journal of Infectious Diseases|August 21, 2004
Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug useAnthony J Freeman, Rosemary A Ffrench, Jeffrey J Post, et al.
Sexual Health|June 7, 2019
A national study of the clinical management of HIV-positive women in Australia: what are the successes and where are the gaps?Michelle L Giles, Aleece MacPhail, Charlotte Bell, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
The Medical Journal of Australia|May 27, 2025
Remote patient monitoring for managing acute COVID-19, and mortality and hospital use in Sydney, New South Wales, 2021-22: a retrospective observational cohort studyMyong Gyu Kim, Phuong Thao Phan, Cambell McMaster, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
The Journal of Infectious Diseases|May 4, 2004
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohortJeffrey J Post, Yong Pan, Anthony J Freeman, et al.
Pageof 8